Clinical Trials on Henoch-Schoenlein Purpura in Sweden

Total 3 results

  • GlaxoSmithKline
    Completed
    LENS - Long-term Eltrombopag Observational Study (LENS)
    Purpura, Thrombocytopaenic, Idiopathic
    United States, Bulgaria, Italy, Peru, Russian Federation, Canada, France, Germany, Hong Kong, Spain, Sweden, United Kingdom, Hungary, Poland, Ukraine, Czech Republic, India, Australia, Tunisia, Puerto Rico, Pakistan
  • Novartis Pharmaceuticals
    Completed
    EXTEND (Eltrombopag Extended Dosing Study) (EXTEND)
    Purpura, Thrombocytopaenic, Idiopathic
    United Kingdom, Hong Kong, United States, Germany, Italy, Netherlands, Spain, Taiwan, Thailand, Canada, Denmark, Pakistan, Romania, Slovenia, Russian Federation, Slovakia, Sweden, Poland, China, New Zealand, Ukraine, Australia, Austria and more
  • Travere Therapeutics, Inc.
    Recruiting
    Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases (EPPIK)
    Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | Minimal Change Disease | Alport Syndrome | IgA Vasculitis
    United States, Italy, Netherlands, Poland, Spain, United Kingdom, Germany, Sweden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe